An 8-week multicenter study to evaluate the efficacy and safety of orally administered valsartan/amlodipine combination based therapy versus amlodipine monotherapy in patients with stage II hypertension.
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2017
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 22 Jun 2006 New trial record.